RW
Academic Journal
Q1Reactions Weekly
Q1Ranking
—Impact Factor
33H-index
—SJR
—Research Score
—Coverage
About Reactions Weekly
Reactions Weekly is an academic journal listed in the JournalsWorld research directory. This profile includes verified journal identifiers, publisher information, research data, recent articles and official links where available.
Journal Metrics
RankingQ1
Impact Factor—
H-index33
SJR—
Research Score—
Coverage—
ISSN0114-9954, 0157-7271, 1179-2051, 2196-5005
Metrics can change by reporting year. Verify time-sensitive values with the publisher or indexing service.
Aims & Scope
The journal publishes research related to Chemotherapy-related skin toxicity, Drug-Induced Adverse Reactions, Cancer Treatment and Pharmacology, Blood disorders and treatments, Pharmacological Effects and Toxicity Studies, Eosinophilic Disorders and Syndromes.
Recent Research Articles
Latest publications matched automatically by ISSN.
Oxaliplatin
2022-03 · DOI: 10.1007/s40278-022-11163-2Lisinopril
2022-03 · DOI: 10.1007/s40278-022-11066-4Eplerenone/verteporfin
2022-03 · DOI: 10.1007/s40278-022-10999-zAcenocoumarol/warfarin
2022-03 · DOI: 10.1007/s40278-022-10806-xCiclosporin
2022-03 · DOI: 10.1007/s40278-022-10914-7Tacrolimus
2022-03 · DOI: 10.1007/s40278-022-11213-5BBIBP-CorV/SARS-COV-2-vaccine-inactivated-Sinovac-Biotech
2022-03 · DOI: 10.1007/s40278-022-10875-3Multiple drugs
2022-03 · DOI: 10.1007/s40278-022-11109-8Mycophenolate mofetil/octreotide/rituximab
2022-03 · DOI: 10.1007/s40278-022-11139-5Antineoplastics
2022-03 · DOI: 10.1007/s40278-022-10843-6Hydroxyzine/rifampicin/ursodeoxycholic-acid
2022-03 · DOI: 10.1007/s40278-022-11026-8Ibrutinib
2022-03 · DOI: 10.1007/s40278-022-11027-8Cemiplimab
2022-03 · DOI: 10.1007/s40278-022-10912-7Travoprost
2022-03 · DOI: 10.1007/s40278-022-11229-4Mesalazine
2022-03 · DOI: 10.1007/s40278-022-11070-3Ciprofloxacin/vancomycin
2022-03 · DOI: 10.1007/s40278-022-10919-7Pantoprazole
2022-03 · DOI: 10.1007/s40278-022-11168-2Carboplatin/gemcitabine
2022-03 · DOI: 10.1007/s40278-022-10903-8Nivolumab
2022-03 · DOI: 10.1007/s40278-022-11155-3Drospirenone/ethinylestradiol
2022-03 · DOI: 10.1007/s40278-022-10981-0Reviews
Community Reviews
No approved community reviews yet. Be the first to contribute a verified experience.
Write a ReviewVersion History
Profile last updated
September 7, 2026 at 11:58 pm
Profile published
September 7, 2026